Englandlelystad

Bicycle Therapeutics and Pepscan Enter Into Partnership to Apply Constrained Peptide Technology in the Development of Novel Biotherapeutics

Older News

CAMBRIDGE, England and LELYSTAD, The Netherlands - Bicycle Therapeutics has obtained a global license from Pepscan to utilize its proprietary constrained peptide chemistry technology.

MORE..